144 related articles for article (PubMed ID: 37226230)
1. COVID-19 pandemic and the quality of antibiotic use in primary care: an interrupted time-series study.
Domingues M; Torre C; Guerreiro JP; Barata P; Correia-Neves M; Rocha J; Sepodes B; Teixeira Rodrigues A
Int J Qual Health Care; 2023 May; 35(2):. PubMed ID: 37226230
[TBL] [Abstract][Full Text] [Related]
2. Effects of restrictive-prescribing stewardship on antibiotic consumption in primary care in China: an interrupted time series analysis, 2012-2017.
Wang X; Tang Y; Liu C; Liu J; Cui Y; Zhang X
Antimicrob Resist Infect Control; 2020 Sep; 9(1):159. PubMed ID: 32977855
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics and the quality indicators for outpatient antibiotic use in Slovakia.
Tesař T; Masaryková L; Porubcová S; Čičová M; Okša M; Malíková K; Lehocká U
Ceska Slov Farm; 2021; 70(6):199-205. PubMed ID: 35236073
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis.
Vermeulen H; Hens N; Catteau L; Catry B; Coenen S
J Antimicrob Chemother; 2023 Oct; 78(10):2572-2580. PubMed ID: 37671788
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
Wang T; Shen L; Yin J; Zhou L; Sun Q
Antimicrob Resist Infect Control; 2022 Dec; 11(1):164. PubMed ID: 36566210
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of an intervention to improve antibiotic-prescribing behaviour in primary care: a controlled, interrupted time-series study.
Teixeira Rodrigues A; Roque F; Piñeiro-Lamas M; Falcão A; Figueiras A; Herdeiro MT
J Antimicrob Chemother; 2019 Sep; 74(9):2788-2796. PubMed ID: 31257435
[TBL] [Abstract][Full Text] [Related]
7. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe.
Adriaenssens N; Coenen S; Versporten A; Muller A; Vankerckhoven V; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi71-77. PubMed ID: 22096068
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic use in Australian and Swedish primary care: a cross-country comparison.
Andersson K; van Driel M; Hedin K; Hollingworth S; Merlo G
Scand J Prim Health Care; 2022 Mar; 40(1):95-103. PubMed ID: 35166180
[TBL] [Abstract][Full Text] [Related]
9. Long-term trend of antibiotic use at public health care institutions in northwest China, 2012-20 -- a case study of Gansu Province.
Cao W; Feng H; Ma Y; Zhao D; Hu X
BMC Public Health; 2023 Jan; 23(1):27. PubMed ID: 36604660
[TBL] [Abstract][Full Text] [Related]
10. Problems in collecting comparable national drug use data in Europe: the example of antibacterials.
Rønning M; Blix HS; Strøm H; Skovlund E; Andersen M; Stichele RV
Eur J Clin Pharmacol; 2003 Apr; 58(12):843-9. PubMed ID: 12698312
[TBL] [Abstract][Full Text] [Related]
11. Consumption of Antibacterials for Systemic Use in Slovakia: A National Study and the Quality Indicators for Outpatient Antibiotic Use.
Tesar T; Masarykova L; Lehocka L; Porubcova S; Cicova M; Wawruch M
Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680761
[TBL] [Abstract][Full Text] [Related]
12. Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics.
Tomic T; Henman M; Tadic I; Antic Stankovic J; Santric Milicevic M; Bukumiric Z; Lakic D; Odalovic M
J Infect Dev Ctries; 2024 Apr; 18(4):504-512. PubMed ID: 38728639
[TBL] [Abstract][Full Text] [Related]
13. [Utilization of antibiotics in and outside of health facilities in Norway in 1998].
Blix HS
Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1731-4. PubMed ID: 10904658
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic consumption in French nursing homes between 2018 and 2022: A multicenter survey.
Bouges S; Jouzeau A; Lieutier-Colas F; Péfau M; Dugravot L; Rogues AM; Simon L; Dumartin C
Infect Control Hosp Epidemiol; 2024 Jun; 45(6):740-745. PubMed ID: 38369786
[TBL] [Abstract][Full Text] [Related]
15. Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.
Lee YT; Tsao SM; Lin HC; Huang HJ; Lee MC; Hsueh PR
Int J Antimicrob Agents; 2010 Dec; 36(6):523-30. PubMed ID: 20855186
[TBL] [Abstract][Full Text] [Related]
16. Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.
Adriaenssens N; Bruyndonckx R; Versporten A; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii30-ii36. PubMed ID: 34312653
[TBL] [Abstract][Full Text] [Related]
17. Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.
Ryu S; Hwang Y; Ali ST; Kim DS; Klein EY; Lau EHY; Cowling BJ
J Infect Dis; 2021 Sep; 224(6):949-955. PubMed ID: 33856455
[TBL] [Abstract][Full Text] [Related]
18. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
[TBL] [Abstract][Full Text] [Related]
19. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
Payerl-Pal M
Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
[TBL] [Abstract][Full Text] [Related]
20. The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland.
Aldeyab MA; Crowe W; Karasneh RA; Patterson L; Sartaj M; Ewing J; Lattyak WJ; Al-Azzam S; Araydah M; Darwish Elhajji F; Kabbaha S; Conway BR; Conlon-Bingham G; Farren D; Scott M
Br J Clin Pharmacol; 2023 Sep; 89(9):2851-2866. PubMed ID: 37160725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
